July 17, 2020

Venturetech Announces New RM15 Million Investment Through Triparte MOU with Duopharma Biotect BHD and Commercial Biosimilar Production Facility

PUTRAJAYA, 17 July – VentureTECH today signed and exchanged a tripartite Memorandum of
Understanding (MoU) with Duopharma Biotech Bhd (Duopharma Biotech) and PanGen Biotech
Inc. (PanGen) toward the establishment of Malaysia’s first commercial biosimilar production
facility in a move to position the country as a regional player in the growing biosimilar market,
whilst improving affordability and accessibility to healthcare in the country.
The MoU signing ceremony was graced and witnessed by the Minister of Science, Technology,
and Innovation (MOSTI), YB Khairy Jamaluddin.

VentureTECH Announce New RM15 Million Investment Through Triparte MOU with Duopharma Biotech Bhd and Pangen Biotech Inc. to Build Malaysia’s First Commercial Biosimilar Production Facility

PUTRAJAYA, 17 July 2020 – VentureTECH today signed and exchanged a tripartite Memorandum of Understanding (MoU) with Duopharma Biotech Bhd (Duopharma Biotech) and PanGen Biotech Inc. (PanGen) toward the establishment of Malaysia’s first commercial biosimilar production facility in a move to position the country as a regional player in the growing biosimilar market, whilst improving affordability and accessibility to healthcare in the country.